Modulation of paclitaxel resistance by annexin IV in human cancer cell lines

A recurring problem with cancer therapies is the development of drug resistance. While investigating the protein profile of cells resistant to a novel antimitotic compound (A204197), we discovered an increase in annexin IV expression. When we examined the annexin IV protein expression level in a pac...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, E Kyu-Ho, Tahir, S K, Cherian, S P, Collins, N, Ng, S-C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374538/
https://www.ncbi.nlm.nih.gov/pubmed/10883672
http://dx.doi.org/10.1054/bjoc.2000.1311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374538/
https://www.ncbi.nlm.nih.gov/pubmed/10883672
http://dx.doi.org/10.1054/bjoc.2000.1311

Ejemplares similares